Skip to content

Enhancing the perception of pain using virtual reality: a pilot study

Enhancing the perception of pain using virtual reality: a pilot study - VR-PainCart pilot

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON50817
Enrollment
24
Registered
2021-01-13
Start date
2021-03-15
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pijn Pain

Interventions

None listed

Sponsors

Centre for Human Drug Research
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Healthy male subjects aged 18-40 years, inclusive; healthy is defined as no clinically relevant abnormalities identified. * Able to participate and willing to give written informed consent and to comply with the study restrictions.

Exclusion criteria

Exclusion criteria: * History of symptoms or any significant including (but not limited to) neurological or psychiatric disorder., if assessed by the Principal Investigator as possibly interfering with the study objectives. * High pain tolerance (80% or higher value for the pain tolerance of the electrical stair test) * Presence of Virtual Reality Sickness (simulator sickness). * Smoker of more than 5 cigarettes per day prior to screening or who use tobacco products equivalent to more than 5 cigarettes per day. * Consume, on average, > 8 units/day of (methyl)-xanthines (e.g. coffee, tea, cola, chocolate) or not able to refrain from use during each stay at the CHDR clinic. * Have a urine drug screen detecting illicit drug of abuse (morphine, benzodiazepines, cocaine, amphetamine, THC, methamphetamines, MDMA) or a positive alcohol breath test;

Design outcomes

Primary

MeasureTime frame
* Electrical Stair: PDT (mA), PTT (mA), Area Under the VAS pain Curve (AUC) (mA*mm), and post-test VAS (mm). * Electrical Stair (including virtual reality simulation without enhancement): PDT (mA), PTT (mA), Area Under the VAS pain Curve (AUC) (mA*mm), and post-test VAS (mm). * Electrical Stair (including virtual reality simulation with enhancement): PDT (mA), PTT (mA), Area Under the VAS pain Curve (AUC) (mA*mm), and post-test VAS (mm).

Secondary

MeasureTime frame
Questionnaires on personal characteristics, stress, anxiety and the relationship with electrial pain detection and tolerance thresholds.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)